Public Health Agency of Canada

New Canadian Cancer Statistics report reveals lung cancer death rates are declining faster than any other cancer type in Canada

Retrieved on: 
Wednesday, November 8, 2023

The annual report – Canadian Cancer Statistics 2023 – was developed by the Canadian Cancer Statistics Advisory Committee in collaboration with CCS, Statistics Canada and the Public Health Agency of Canada.

Key Points: 
  • The annual report – Canadian Cancer Statistics 2023 – was developed by the Canadian Cancer Statistics Advisory Committee in collaboration with CCS, Statistics Canada and the Public Health Agency of Canada.
  • While the age-standardized lung cancer death rates have decreased substantially, an estimated 20,600 people are expected to die from lung cancer (9,800 females and 10,800 males) in Canada in 2023.
  • The most significant reason that lung cancer death rates are improving is due to a reduction in commercial tobacco use, which is the leading risk factor for lung cancer.
  • "By investing more into lung cancer research, we gain critical insights about lung cancer and disease progression that will enable us to develop better treatments for lung cancer patients."

New Report Offers Guidance on Radon Testing Devices Safeguarding Canadians Against Lung Cancer

Retrieved on: 
Wednesday, November 1, 2023

The report offers recommendations to evaluate indoor air quality and safeguard Canadians against lung cancer from radon exposure.

Key Points: 
  • The report offers recommendations to evaluate indoor air quality and safeguard Canadians against lung cancer from radon exposure.
  • "Radon continues to be a leading cause of lung cancer in non-smokers," says Nancy Wirtz, Manager, Cancer Prevention at the Canadian Cancer Society.
  • In October 2021, Winnipeg native Corie Haslbeck received a devastating stage 4 lung cancer diagnosis after being exposed to elevated levels of radon.
  • The first step that Canadians can take to protect themselves against lung cancer is to test their home for radon.

New Report Highlights Significant Gaps In Arthritis Care And Research Across Canada

Retrieved on: 
Monday, October 23, 2023

TORONTO, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Arthritis Society Canada today released The State of Arthritis in Canada Report Card, giving low grades to all provinces and territories, underscoring the urgent need for action and innovation in the field of arthritis care.

Key Points: 
  • TORONTO, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Arthritis Society Canada today released The State of Arthritis in Canada Report Card, giving low grades to all provinces and territories, underscoring the urgent need for action and innovation in the field of arthritis care.
  • “We have a growing arthritis crisis in this country,” said Trish Barbato, president and CEO at Arthritis Society Canada.
  • The Public Health Agency of Canada and Statistics Canada can work with the arthritis community and provinces/territories to collect better arthritis data.
  • “More than six million Canadians have arthritis – that’s one in five,” said Siân Bevan, Chief Science Officer, Arthritis Society Canada.

Indivior Publishes Real World Data Showing SUBLOCADE® May Reduce Non-Fatal Overdoses Among Individuals with Opioid Use Disorder in Canada

Retrieved on: 
Tuesday, September 26, 2023

This study, conducted during the COVID-19 pandemic in Canada, also showed improvements in additional parameters suggestive of clinical benefit.

Key Points: 
  • This study, conducted during the COVID-19 pandemic in Canada, also showed improvements in additional parameters suggestive of clinical benefit.
  • The percentage of individuals with urinary drug screen (UDS)-detected fentanyl use within the first month of treatment was 23% with SUBLOCADE; 22% with sublingual buprenorphine/naloxone, and 66% with methadone.
  • During the six months following the initiation of treatment, UDS-detected fentanyl use decreased to 13% with SUBLOCADE, 10% with sublingual buprenorphine/naloxone, and 51% with methadone.
  • "This study shows the potential positive impact of using SUBLOCADE in OUD treatment to help reduce non-fatal opioid overdoses in Canada, including from fentanyl use," said Christian Heidbreder, PhD, Chief Scientific Officer, Indivior.

It’s Back to School Across Ontario and Jack.org Has Launched a New Resource

Retrieved on: 
Wednesday, September 13, 2023

TORONTO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- In response to the growing need for comprehensive mental health education for young people, Jack.org is launching its groundbreaking Educator Hub (edHUB), a free library of classroom-ready mental health lesson plans and activities for educators. This new offering empowers high school teachers with the resources to easily bring mental health learning to their classrooms to help safeguard the health and wellbeing of their students.

Key Points: 
  • This new offering empowers high school teachers with the resources to easily bring mental health learning to their classrooms to help safeguard the health and wellbeing of their students.
  • One out of every five young people will experience a mental health disorder but many of them lack the essential mental health education that would help them get the support they need.
  • Jack.org recognizes the role that education systems play in ensuring young people have access to quality information about mental health and struggle early on.
  • It also includes guides for educators to use to brush up on their own mental health knowledge and build a safe classroom environment for mental health discussion.

Aspira Women’s Health Announces Dr. Jody Berry as New Chief Scientific Officer

Retrieved on: 
Monday, September 11, 2023

AUSTIN, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynecologic diseases, today announced it has named Jody Berry, Ph.D. as its new Chief Scientific Officer.

Key Points: 
  • AUSTIN, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynecologic diseases, today announced it has named Jody Berry, Ph.D. as its new Chief Scientific Officer.
  • Dr. Berry is a seasoned scientific leader with over two decades of commercial, government and academic experience.
  • Jody is a dynamic leader with decades of experience launching disruptive products and building effective research and development teams,” said Nicole Sandford, Chief Executive Officer of Aspira.
  • Dr. Berry is author or co-author on over 100 peer-reviewed published journal articles, abstracts, scientific posters, and monographs.

Expert Panel describes path to bring critical antibiotics to Canadian market

Retrieved on: 
Thursday, September 7, 2023

Canada is lagging behind peer countries on access to existing drugs, and a new expert panel report describes a pathway to a more stable supply of antimicrobials in the future.

Key Points: 
  • Canada is lagging behind peer countries on access to existing drugs, and a new expert panel report describes a pathway to a more stable supply of antimicrobials in the future.
  • “The consequences of antimicrobial resistance are real and growing, while at the same time, companies are leaving the commercial space,” said Andrew M. Morris, M.D., Chair of the Expert Panel.
  • The cumulative costs to Canadian healthcare systems could reach $120 billion by 2050 as resistance rates increase.
  • Overcoming Resistance describes the challenges Canada faces when accessing high-value antimicrobials and describes pull incentives that could help bring existing antimicrobials to market and encourage the development of new ones.

THE YMCA AND WALK OFF THE EARTH REIMAGINE THE Y.M.C.A. ANTHEM, FOCUSING ON YOUTH MENTAL HEALTH

Retrieved on: 
Monday, August 28, 2023

The musical collaboration introduces expanded access to the YMCA's free youth mental health program,

Key Points: 
  • The musical collaboration introduces expanded access to the YMCA's free youth mental health program,
    TORONTO, Aug. 28, 2023 /CNW/ - YMCA Canada and Canadian indie pop band Walk off the Earth today released a modern take on the Y.M.C.A.
  • anthem to raise awareness of expanded access to the free youth mental health program, Y Mind.
  • Alongside the new musical arrangement, Walk off the Earth has also released an accompanying full-length music video now available on YouTube .
  • "Mental health is health, and everyone, including Juno Award winners, like Walk off the Earth, are opening up and having conversations about their mental health.

First of its kind BrainFit-Habit Tracker app now available in French

Retrieved on: 
Tuesday, August 22, 2023

TORONTO, Aug. 22, 2023 /CNW/ - Exciting news today, as the highly successful BrainFit-Habit Tracker app is now available for download in French on both iOS and Android.

Key Points: 
  • TORONTO, Aug. 22, 2023 /CNW/ - Exciting news today, as the highly successful BrainFit-Habit Tracker app is now available for download in French on both iOS and Android.
  • BrainFit-Habit Tracker is a unique mobile app created by Women's Brain Health Initiative (WBHI) to help users prevent dementia and optimize their brain health.
  • "We are thrilled to announce that our successful BrainFit-Habit Tracker app is now available in French," said Lynn Posluns, WBHI President and CEO.
  • Download BrainFit today in French and English:
    For more information on the BrainFit-Habit Tracker app: www.brainfit.org

More than 75% of Canadians had immunity to SARS-CoV-2 due to infection by March 2023

Retrieved on: 
Monday, August 14, 2023

Today, the COVID-19 Immunity Task Force (CITF) published the most comprehensive peer-reviewed analysis of pan-Canadian seroprevalence estimates in CMAJ (Canadian Medical Association Journal) .

Key Points: 
  • Today, the COVID-19 Immunity Task Force (CITF) published the most comprehensive peer-reviewed analysis of pan-Canadian seroprevalence estimates in CMAJ (Canadian Medical Association Journal) .
  • Three time periods were analyzed: pre-vaccination (March 2020 to November 2020); vaccine roll-out (December 2020 to November 2021); and the Omicron waves (December 2021 to March 2023).
  • The low infection rates in Canada before Omicron were observed in other high-income countries in Europe and North America as well.
  • “By March 2023, roughly 80% of adults aged 18-25 had evidence of a previous infection.